A detailed history of Clayton Financial Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Clayton Financial Group LLC holds 21 shares of INCY stock, worth $2,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$2,187
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 21, 2026

BUY
$83.8 - $108.26 $1,759 - $2,273
21 New
21 $2.08 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Clayton Financial Group LLC Portfolio

Follow Clayton Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Financial Group LLC with notifications on news.